1. Home
  2. PLCE vs RANI Comparison

PLCE vs RANI Comparison

Compare PLCE & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Children's Place Inc. (The)

PLCE

Children's Place Inc. (The)

HOLD

Current Price

$2.84

Market Cap

92.8M

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.74

Market Cap

106.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLCE
RANI
Founded
1969
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.8M
106.9M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
PLCE
RANI
Price
$2.84
$0.74
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$3.50
$7.50
AVG Volume (30 Days)
448.1K
765.7K
Earning Date
04-10-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
11.48
57.14
EPS
N/A
N/A
Revenue
N/A
$1,633,000.00
Revenue This Year
N/A
$274.77
Revenue Next Year
$4.41
$79.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
58.85
52 Week Low
$2.76
$0.39
52 Week High
$9.56
$3.87

Technical Indicators

Market Signals
Indicator
PLCE
RANI
Relative Strength Index (RSI) 34.33 38.45
Support Level N/A $0.71
Resistance Level $3.81 $0.83
Average True Range (ATR) 0.26 0.05
MACD -0.09 -0.00
Stochastic Oscillator 2.59 22.52

Price Performance

Historical Comparison
PLCE
RANI

About PLCE Children's Place Inc. (The)

Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: